BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16207609)

  • 21. Subcellular localization pattern of protoporphyrin IX is an important determinant for its photodynamic efficiency of human carcinoma and normal cell lines.
    Ji Z; Yang G; Vasovic V; Cunderlikova B; Suo Z; Nesland JM; Peng Q
    J Photochem Photobiol B; 2006 Sep; 84(3):213-20. PubMed ID: 16709459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 5-aminolevulinic acid-incorporated nanoparticles of methoxy poly(ethylene glycol)-chitosan copolymer for photodynamic therapy.
    Chung CW; Chung KD; Jeong YI; Kang DH
    Int J Nanomedicine; 2013; 8():809-19. PubMed ID: 23589688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of surfactant on 5-aminolevulinic acid uptake and PpIX generation in human cholangiocarcinoma cell.
    Chung CW; Kim CH; Choi KH; Yoo JJ; Kim DH; Chung KD; Jeong YI; Kang DH
    Eur J Pharm Biopharm; 2012 Feb; 80(2):453-8. PubMed ID: 22024407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human glioblastoma stem-like cells accumulate protoporphyrin IX when subjected to exogenous 5-aminolaevulinic acid, rendering them sensitive to photodynamic treatment.
    Schimanski A; Ebbert L; Sabel MC; Finocchiaro G; Lamszus K; Ewelt C; Etminan N; Fischer JC; Sorg RV
    J Photochem Photobiol B; 2016 Oct; 163():203-10. PubMed ID: 27588717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topical application of 5-aminolevulinic acid hexyl ester and 5-aminolevulinic acid to normal nude mouse skin: differences in protoporphyrin IX fluorescence kinetics and the role of the stratum corneum.
    van den Akker JT; Iani V; Star WM; Sterenborg HJ; Moan J
    Photochem Photobiol; 2000 Nov; 72(5):681-9. PubMed ID: 11107855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel potential photodynamic therapy strategy using 5-Aminolevulinic acid for ovarian clear-cell carcinoma.
    Teshigawara T; Mizuno M; Ishii T; Kitajima Y; Utsumi F; Sakata J; Kajiyama H; Shibata K; Ishizuka M; Kikkawa F
    Photodiagnosis Photodyn Ther; 2018 Mar; 21():121-127. PubMed ID: 29196245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A quantitative assessment of protoporphyrin IX metabolism and phototoxicity in human skin following dose-controlled delivery of the prodrugs 5-aminolaevulinic acid and 5-aminolaevulinic acid-n-pentylester.
    Gerscher S; Connelly JP; Beijersbergen Van Henegouwen GM; MacRobert AJ; Watt P; Rhodes LE
    Br J Dermatol; 2001 May; 144(5):983-90. PubMed ID: 11359385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aminolevulinic acid derivatives-based photodynamic therapy in human intra- and extrahepatic cholangiocarcinoma cells.
    Chung CW; Kim CH; Lee HM; Kim DH; Kwak TW; Chung KD; Jeong YI; Kang DH
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):503-10. PubMed ID: 23429232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of Silencing Heme Biosynthesis Enzymes on 5-Aminolevulinic Acid-mediated Protoporphyrin IX Fluorescence and Photodynamic Therapy.
    Yang X; Li W; Palasuberniam P; Myers KA; Wang C; Chen B
    Photochem Photobiol; 2015; 91(4):923-30. PubMed ID: 25809721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clearance mechanism of protoporphyrin IX from mouse skin after application of 5-aminolevulinic acid.
    Juzeniene A; Iani V; Moan J
    Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):538-45. PubMed ID: 24284108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of light fractionation with a 2-h dark interval on the efficacy of topical hexyl-aminolevulinate photodynamic therapy in normal mouse skin.
    Middelburg TA; de Bruijn HS; van der Ploeg-van den Heuvel A; Neumann HA; Robinson DJ
    Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):703-9. PubMed ID: 24284130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topical delivery of 5-aminolevulinic acid-encapsulated ethosomes in a hyperproliferative skin animal model using the CLSM technique to evaluate the penetration behavior.
    Fang YP; Huang YB; Wu PC; Tsai YH
    Eur J Pharm Biopharm; 2009 Nov; 73(3):391-8. PubMed ID: 19660544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A vehicle for photodynamic therapy of skin cancer: influence of dimethylsulphoxide on 5-aminolevulinic acid in vitro cutaneous permeation and in vivo protoporphyrin IX accumulation determined by confocal microscopy.
    De Rosa FS; Marchetti JM; Thomazini JA; Tedesco AC; Bentley MV
    J Control Release; 2000 Apr; 65(3):359-66. PubMed ID: 10699294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sustained and efficient porphyrin generation in vivo using dendrimer conjugates of 5-ALA for photodynamic therapy.
    Casas A; Battah S; Di Venosa G; Dobbin P; Rodriguez L; Fukuda H; Batlle A; MacRobert AJ
    J Control Release; 2009 Apr; 135(2):136-43. PubMed ID: 19168101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancing the efficiency of 5-aminolevulinic acid-mediated photodynamic therapy using 5-fluorouracil on human melanoma cells.
    Tahmasebi H; Khoshgard K; Sazgarnia A; Mostafaie A; Eivazi MT
    Photodiagnosis Photodyn Ther; 2016 Mar; 13():297-302. PubMed ID: 26321747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic photodynamic therapy with aminolevulinic acid induces apoptosis in lesional T lymphocytes of psoriatic plaques.
    Bissonnette R; Tremblay JF; Juzenas P; Boushira M; Lui H
    J Invest Dermatol; 2002 Jul; 119(1):77-83. PubMed ID: 12164928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improvement of the efficacy of 5-aminolevulinic acid-mediated photodynamic treatment in human oral squamous cell carcinoma HSC-4.
    Yamamoto M; Fujita H; Katase N; Inoue K; Nagatsuka H; Utsumi K; Sasaki J; Ohuchi H
    Acta Med Okayama; 2013; 67(3):153-64. PubMed ID: 23804138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro/in vivo correlations between transdermal delivery of 5-aminolaevulinic acid and cutaneous protoporphyrin IX accumulation and effect of formulation.
    Tsai JC; Chen IH; Wong TW; Lo YL
    Br J Dermatol; 2002 May; 146(5):853-62. PubMed ID: 12000384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 5-Aminolevulinic acid-mediated photodynamic therapy can target human glioma stem-like cells refractory to antineoplastic agents.
    Fujishiro T; Nonoguchi N; Pavliukov M; Ohmura N; Kawabata S; Park Y; Kajimoto Y; Ishikawa T; Nakano I; Kuroiwa T
    Photodiagnosis Photodyn Ther; 2018 Dec; 24():58-68. PubMed ID: 29990642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oleic acid as optimizer of the skin delivery of 5-aminolevulinic acid in photodynamic therapy.
    Pierre MB; Ricci E; Tedesco AC; Bentley MV
    Pharm Res; 2006 Feb; 23(2):360-6. PubMed ID: 16341572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.